Literature DB >> 15572005

Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India.

S Chaudhuri1, S Das, A Chowdhury, A Santra, S K Bhattacharya, T N Naik.   

Abstract

BACKGROUND: In recent years, hepatitis C virus (HCV) infection is gaining importance in Asian countries. Recent studies conducted in different parts of the world revealed that there is a genotypic correlation of disease severity and treatment outcome.
OBJECTIVES: A detailed study was carried out to delineate the genotypic distribution of HCV among acute and chronic liver disease patients in Kolkata, a city in eastern India. STUDY
DESIGN: Acute and chronic liver disease was diagnosed among patients attending hepatitis clinics in the city. Anti-HCV ELISA was performed on the blood samples of the cases and positive samples were tested for presence of HCV-RNA and genotyping of the samples were carried out by reverse transcription and polymerase chain reaction (RT-PCR) and sequencing.
RESULTS: Seroprevalence of HCV infection among acute (11.0%) and chronic (25.3%) hepatitis patients were high and among them 97 (75.8%) and 323 (86.1%) were HCV-RNA positive for acute and chronic hepatitis patients, respectively. Genotyping by PCR showed that the predominant genotype was 3b (42.3%) followed by 3a (28.9%) among acute hepatitis group whereas among chronic hepatitis group, the most prevalent genotypes were 3a (34.7%) and 3b (47.7%). Sequence analysis of the untypeable isolates revealed the presence of a rare subtype 6b.
CONCLUSIONS: The study revealed very high prevalence of HCV among acute and chronic hepatitis patients with predominance of genotype 3. Subtype 6b was commonly found in Thailand but not in India. The detection of this rare strain of Thai origin reveals the spread of HCV infection from Thailand to other parts of Asia. This observation necessitates further intensive surveillance of HCV infection in India to unravel the distribution of genotypes in the country and to correlate disease severity and treatment outcome to the genotype prevalence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15572005     DOI: 10.1016/j.jcv.2004.07.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  11 in total

1.  Primer sequence modification enhances hepatitis C virus genotype coverage.

Authors:  Yi-Wei Tang; Susan E Sefers; Haijing Li
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 2.  Hepatitis C in India.

Authors:  Ashis Mukhopadhyaya
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

3.  Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India.

Authors:  Arup Banerjee; Sibnarayan Datta; Partha K Chandra; Susanta Roychowdhury; Chinmoy Kumar Panda; Runu Chakravarty
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 4.  Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?

Authors:  Ijaz-S Jamall; Shafaq Yusuf; Maimoona Azhar; Selene Jamall
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

5.  Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata.

Authors:  Kallol Saha; Rushna Firdaus; Poonam Santra; Jyotirmoy Pal; Arnab Roy; Mihir K Bhattacharya; Sekhar Chakrabarti; Provash C Sadhukhan
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

6.  Diversity of genotype and mode of spread of Hepatitis C virus in Northern India.

Authors:  Harmeet S Rehan; Seema Manak; Madhur Yadav; Deepti Chopra; Neeta Wardhan
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

7.  Viral genotypes and associated risk factors of hepatocellular carcinoma in India.

Authors:  Manash Pratim Sarma; Mohammad Asim; Subhash Medhi; Thayumanavan Bharathi; Richa Diwan; Premashis Kar
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

Review 8.  An overview of molecular epidemiology of hepatitis B virus (HBV) in India.

Authors:  Sibnarayan Datta
Journal:  Virol J       Date:  2008-12-19       Impact factor: 4.099

Review 9.  A juggernaut of innate & adaptive immune cells in chronic hepatitis C.

Authors:  Shallu Tomer; Sunil K Arora
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

10.  Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.

Authors:  Aritra Biswas; Rushna Firdaus; Kallol Saha; Prosanto Chowdhury; Debyojyoti Bhattacharya; Maitreyee Bhattacharyya; Provash Chandra Sadhukhan
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.